| [1] Zhang B, Shen Q, Chen Y, et al. Myricitrin alleviates oxidative stress-induced inflammation and apoptosis and protects mice against diabetic cardiomyopathy[J]. Sci Rep, 2017, 7: 44239.
[2] Miyazaki T, Koya T, Kigawa Y, et al. Calpain and atherosclerosis[J]. J Atheroscler Thromb, 2013, 20(3): 228-237.
[3] Shah MS, Brownlee M. Molecular and cellular mechanisms of cardiovascular disorders in diabetes[J]. Circ Res, 2016, 118(11): 1808-1829.
[4] Liu J, Shen Q, Wu Y. Simvastatin prevents cardiac hypertrophy in vitro and in vivo via JAK/STAT pathway[J]. Life Sci, 2008, 82(19-20): 991-996.
[5] Al-Rasheed NM, Al-Rasheed NM, Hasan IH, et al. Simvastatin ameliorates diabetic cardiomyopathy by attenuating oxidative stress and inflammation in rats[J]. Oxid Med Cell Longev, 2017, 2017: 1092015.
[6] 陈晨 ，王洪新，张英杰，等. 黄芪甲苷通过AMPK/mTOR信号通路改善STZ诱导的糖尿病大鼠的心肌损害[J]. 中药药理与临床, 2018, 34(3): 80-85.
[7] Vulesevic B, Mcneill B, Giacco F, et al. Methylglyoxal-induced endothelial cell loss and inflammation contribute to the development of diabetic cardiomyopathy[J]. Diabetes, 2016, 65(6): 1699-1713.
[8] Othman AI, El-sawi MR, El-missiry MA, et al. Epigallocatechin-3-gallate protects against diabetic cardiomyopathy through modulating the cardiometabolic risk factors, oxidative stress, inflammation, cell death and fibrosis in streptozotocin-nicotinamide-induced diabetic rats[J]. Biomed Pharmacother, 2017, 94: 362-373.
[9] Seddon M, Looi YH, Shah AM. Oxidative stress and redox signalling in cardiac hypertrophy and heart failure[J]. Heart, 2007, 93(8): 903-907.
[10] Yin M, Liu Q, Yu L, et al. Downregulations of CD36 and calpain-1, inflammation, and atherosclerosis by simvastatin in apolipoprotein E knockout mice[J]. J Vasc Res, 2017, 54(3): 123-130.
[11]Choi H, Myung K. Calcitriol enhances fat synthesis factors and calpain activity in co-cultured cells[J]. Cell Biol Int, 2014, 38(8): 910-917.
[12]Li Q, Harraz MM, Zhou W, et al. Nox2 and Rac1 regulate H2O2-dependent recruitment of TRAF6 to endosomal interleukin-1 receptor complexes[J]. Mol Cell Biol, 2006, 26(1): 140-154.
[13]Li Y, Ma J, Zhu H, et al. Targeted inhibition of calpain reduces myocardial hypertrophy and fibrosis in mouse models of type 1 diabetes[J]. Diabetes, 2011, 60(11): 2985-2994.
[14]Li X, Luo R, Chen R, et al. Cleavage of IκBα by calpain induces myocardial NF-kappaB activation, TNF-alpha expression, and cardiac dysfunction in septic mice[J]. Am J Physiol Heart Circ Physiol, 2014, 306(6): H833-H843.
[15]O'neill WC, Lomashvili KA, Malluche HH, et al. Treatment with pyrophosphate inhibits uremic vascular calcification[J]. Kidney Int, 2011, 79(5): 512-517. |
京ICP备08002354号-3
